Abstract
INTRODUCTION AND IMPORTANCE: Phosphatase and tensin homolog (PTEN) hamartomas comprise a spectrum of disorders that involve multiple systems and originate from a group of allelic disorders from germ line mutations in the PTEN gene. PTEN hamartomas involve a spectrum of disorders with diversed clinical manifestations and diagnosis can be challenging, particularly when lesions mimic other conditions. CASE PRESENTATION: We present a case of a PTEN hamartoma in an eighteen-year-old male, who presented with a history of swelling on the chin with episodic bleeds. Initial diagnosis of an arteriovenous malformation was made radiologically but was later confirmed by histopathological and immunohistochemistry to be a case of PTEN hamartoma. DISCUSSION: PTEN is a tumor suppressor gene, and patients with germline PTEN mutations are more likely to develop malignancies, particularly epithelial, mesenchymal, and hematopoietic cancers. PTEN hamartomas cause a variety of conditions, including Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, PTEN-related Proteus syndrome, and Proteus-like syndrome. As a result, cancer surveillance is critical in managing PTEN hamartoma tumor syndrome (PTHS) patients. All PTEN mutation carriers should adhere to approved cancer surveillance measures. CONCLUSION: This case highlights the unusual presentation of PTHS. It can present as an isolated PTEN hamartoma of Soft Tissue (PHOST) lesion without systemic findings and establishing a genetic diagnosis is important to the patient's future health. A multidisciplinary approach with the clinical, radiologic and pathologic findings of PTHS and PHOST lesions will more rapidly lead to an accurate diagnosis. Prompt diagnosis and appropriate treatment are important to prevent potentially severe outcomes.